How AI might help identify adverse drug events

The development of natural language processing (NLP) capabilities is opening new avenues for pharmacovigilance and pharmacists can play a key role in the process. US...

The new normal

A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...

Indirect impacts of COVID-19

Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.

Choosing Wisely: new medicines advice service arrives

The Pharmaceutical Society of Australia (PSA) has released a list of recommendations for healthcare professionals to ensure the safe use of medicines. The launch of...

Bringing pharmacists into the digital future

PSA has unveiled a new digital health report, Connecting the dots: Digitally empowered pharmacists, at the PSA19 conference. The report, funded by the Australian Digital...

A voice for Australia and New Zealand at IPSF 2025

Australia and New Zealand had a voice at the IPSF World Congress, influencing discussions on education, practice and global health.